{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:40:35Z","timestamp":1790052035122,"version":"4.0.1"},"reference-count":31,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:00:00Z","timestamp":1539216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH K22 [ES023850]"],"award-info":[{"award-number":["NIH K22 [ES023850]"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001287","name":"Elsa U. Pardee Foundation","doi-asserted-by":"publisher","award":["[670645]"],"award-info":[{"award-number":["[670645]"]}],"id":[{"id":"10.13039\/100001287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Platelet-activating factor-receptor (PAF-R) agonists are pleiotropic lipid factors that influence multiple biological processes, including the induction and resolution of inflammation as well as immunosuppression. PAF-R agonists have been shown to modulate tumorigenesis and\/or tumor growth in various skin cancer models by suppressing either cutaneous inflammation and\/or anti-tumoral adaptive immunity. We have previously shown that a chronic systemic PAF-R agonist administration of mice enhances the growth of subcutaneously implanted melanoma tumors. Conversely, chronic topical applications of a PAF-R agonist suppressed non-melanoma skin cancer (NMSC) in a topical chemical carcinogenesis model (dimethylbenz[a]anthracene\/phorbol 12-myristate 13-acetate (DMBA\/PMA)) in-part via anti-inflammatory effects. These results indicate that the context of PAF-R agonist exposure via either chronic cutaneous or systemic administration, result in seemingly disparate effects on tumor promotion. To further dissect the contextual role of PAF-R agonism on tumorigenesis, we chronically administered systemic PAF-R agonist, carbamoyl-PAF (CPAF) to mice under a cutaneous chemical carcinogenesis protocol, recently characterized to initiate both NMSC and melanocytic nevus formation that can progress to malignant melanoma. Our results showed that while systemic CPAF did not modulate melanocytic nevus formation, it enhanced the growth of NMSC tumors.<\/jats:p>","DOI":"10.3390\/ijms19103109","type":"journal-article","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T02:58:04Z","timestamp":1539313084000},"page":"3109","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Systemic Platelet-Activating Factor-Receptor Agonism Enhances Non-Melanoma Skin Cancer Growth"],"prefix":"10.3390","volume":"19","author":[{"given":"Eric","family":"Romer","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Thyagarajan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Department of Pathology and Dermatology, Boonshoft School of Medicine, Wright State University, Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Rapp","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langni","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Fahy","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeezat","family":"Awoyemi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi P.","family":"Sahu","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University; Dayton, OH 45435, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1080\/714037693","article-title":"Platelet activating factor, a pleiotrophic mediator of physiological and pathological processes","volume":"30","author":"Stafforini","year":"2003","journal-title":"Crit. Rev. Clin. Lab Sci."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prostaglandins.2008.04.002","article-title":"Oxidized glycerophosphocholines as biologically active mediators for ultraviolet radiation mediated effects","volume":"87","author":"Konger","year":"2008","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.enz.2015.09.004","article-title":"Plasma PAF-AH (PLA2G7): Biochemical Properties, Association with LDLs and HDLs, and Regulation of Expression","volume":"38","author":"Stafforini","year":"2015","journal-title":"Enzymes"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1194\/jlr.R045492","article-title":"To hydrolyze or not to hydrolyze: The dilemma of platelet-activating factor acetylhydrolase","volume":"55","author":"Marathe","year":"2014","journal-title":"J. Lipid Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1084\/jem.20011450","article-title":"Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression","volume":"195","author":"Walterscheid","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1038\/sj.jid.5701251","article-title":"UVB radiation-mediated inhibition of contact hypersensitivity reactions is dependent on the platelet-activating factor system","volume":"128","author":"Zhang","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/carcin\/bgs152","article-title":"The environmental stressor ultraviolet B radiation inhibits murine antitumor immunity through its ability to generate platelet-activating factor agonists","volume":"33","author":"Sahu","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"L47","DOI":"10.1152\/ajplung.00179.2011","article-title":"Lung endothelial cell platelet-activating factor production and inflammatory cell adherence are increased in response to cigarette smoke component exposure","volume":"302","author":"Sharma","year":"2012","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1172\/JCI119417","article-title":"Vitamin C blocks inflammatory platelet-activating factor mimetics created by cigarette smoking","volume":"99","author":"Lehr","year":"1997","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.4049\/jimmunol.1202699","article-title":"Cigarette Smoke Exposure Inhibits Contact Hypersensitivity via the Generation of Platelet-Activating Factor Agonists","volume":"190","author":"Sahu","year":"2013","journal-title":"J. Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.taap.2003.07.014","article-title":"Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression","volume":"195","author":"Ramos","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/carcin\/bgr322","article-title":"Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis","volume":"33","author":"Sahu","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/labinvest.2013.155","article-title":"Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis","volume":"94","author":"Braga","year":"2014","journal-title":"Lab Investig."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.4049\/jimmunol.1701145","article-title":"Platelet-activating factor-induced reduction in contact hypersensitivity is mediated by mast cells via cyclooxygenase-2-dependent mechanisms","volume":"200","author":"Ocana","year":"2018","journal-title":"J. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"da Silva Junior, I.A., Stone, S.C., Rossetti, R.M., Jancar, S., and Lepique, A.P. (2017). Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor. J. Immunol. Res.","DOI":"10.1155\/2017\/5482768"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"32092","DOI":"10.1038\/srep32092","article-title":"PAFR activation of NF-\u03baB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages","volume":"6","author":"Ishizuka","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CS20150538","article-title":"PAFR in adipose tissue macrophages is associated with anti-inflammatory phenotype and metabolic homoeostasis","volume":"130","author":"Filgueiras","year":"2016","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_18","first-page":"139","article-title":"An essential role for platelet-activating factor in activating mast cell migration following ultraviolet irradiation","volume":"95","author":"Chen","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Sahu, R.P., Rezania, S., Ocana, J.A., DaSilva-Arnold, S.C., Bradish, J.R., Richey, J.D., Warren, S.J., Rashid, B., Travers, J.B., and Konger, R.L. (2014). Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111608"},{"key":"ref_20","first-page":"191","article-title":"The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection","volume":"17","author":"Kelesidis","year":"2015","journal-title":"AIDS Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jaci.2015.04.019","article-title":"Platelets in the immune response: Revisiting platelet-activating factor in anaphylaxis","volume":"135","author":"Gill","year":"2015","journal-title":"J. Allergy. Clin. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/sj.bjp.0705731","article-title":"Sponge-induced angiogenesis and inflammation in PAF receptor-deficient mice (PAFR-KO)","volume":"141","author":"Ferreira","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"de Oliveira, S.I., Andrade, L.N., Onuchic, A.C., Nonogaki, S., Fernandes, P.D., Pinheiro, M.C., Rohde, C.B., Chammas, R., and Jancar, S. (2010). Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer, 10.","DOI":"10.1186\/1471-2407-10-200"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1038\/oncsis.2016.90","article-title":"Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy","volume":"6","author":"Chammas","year":"2017","journal-title":"Oncogenesis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"20788","DOI":"10.18632\/oncotarget.7878","article-title":"Radiation therapy generates platelet-activating factor agonists","volume":"7","author":"Sahu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7069","DOI":"10.1158\/0008-5472.CAN-14-2043","article-title":"Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor","volume":"74","author":"Sahu","year":"2014","journal-title":"Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Filler, R.B., Roberts, S.J., and Girardi, M. (2007). Cutaneous two-stage chemical carcinogenesis. CSH Protoc.","DOI":"10.1101\/pdb.prot4837"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/mc.22310","article-title":"A murine model for the development of melanocytic nevi and their progression to melanoma","volume":"55","author":"Nasti","year":"2016","journal-title":"Mol. Carcinog."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1365-2133.2003.05735.x","article-title":"Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin","volume":"149","author":"Niwa","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3892\/mmr.2015.3371","article-title":"Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells","volume":"12","author":"Sahu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/emboj\/16.1.133","article-title":"Bronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor","volume":"16","author":"Ishii","year":"1997","journal-title":"EMBO J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/3109\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:24:53Z","timestamp":1760196293000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/19\/10\/3109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,11]]},"references-count":31,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"alternative-id":["ijms19103109"],"URL":"https:\/\/doi.org\/10.3390\/ijms19103109","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,11]]}}}